Blood-platelet screening in midlife could identify early risk for Alzheimer’s disease
Researchers found a link between platelet aggregation and Alzheimer's biomarkers in midlife, suggesting a potential early warning sign. The study analyzed 382 participants and found that stronger platelet clumping was associated with higher levels of amyloid and tau proteins.